Fortrea Holdings FTRE
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$726.0K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 38.9% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 12.09% to 8.88% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Penn Capital Management Company, LLC | Mutual Fund | 2026/Q3 | +1,140,647 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +803,505 | 17.2% |
| Invesco Capital Management LLC | Mutual Fund | 2026/Q3 | +776,725 | 1.5% |
| Jupiter Fund Management Plc | Mutual Fund | 2026/Q3 | +493,610 | 0.5% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +356,784 | 2.1% |
| First Eagle Investment Management, LLC | Mutual Fund | 2026/Q3 | +305,335 | 0.3% |
| JPMorgan Chase & Co. | Public Company | 2026/Q3 | +272,719 | 0.4% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +263,439 | 0.7% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +214,955 | 0.5% |
| FMR | Mutual Fund | 2026/Q3 | +158,112 | 3.9% |
| Anshul Thakral | Individual/Insider | 2026/Q3 | +204,940 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +2,402,696 | 3.8% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +2,384,349 | 2.5% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +828,772 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +646,709 | 16.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 10 Sep 2026 | Jill McConnell | Officer | Intent to Sell (Form 144) | -1,032 | $17.14 | – |
| 9 Sep 2026 | Jill McConnell | Officer | Intent to Sell (Form 144) | -1,071 | $16.53 | – |
| 9 Sep 2026 | Jason Knoblauch | Chief Financial Officer | Other Derivative Acquisition | +144,434 | – | 144,434 |
| 8 Sep 2026 | Jill McConnell | Officer | Intent to Sell (Form 144) | -1,051 | $16.85 | – |
| 8 Sep 2026 | Mark Morais | COO & President of Clinical Services | Intent to Sell (Form 144) | -3,149 | $16.85 | – |
| 8 Sep 2026 | Carrie Russell | VP of Accounting & Chief Accounting Officer | Intent to Sell (Form 144) | -246 | $16.85 | – |
| 8 Sep 2026 | Mark Morais | COO & President of Clinical Services | Derivative Exercise and Sale | -3,149 | $16.85 | 86,419 |
| 8 Sep 2026 | Carrie Russell | VP of Accounting & Chief Accounting Officer | Derivative Exercise and Sale | -246 | $16.85 | 2,384 |
| 7 Sep 2026 | Mark Morais | COO & President of Clinical Services | Derivative Exercise and Retained | +4,008 | – | 86,419 |
| 7 Sep 2026 | Carrie Russell | VP of Accounting & Chief Accounting Officer | Derivative Exercise and Retained | +604 | – | 2,384 |
| 18 Aug 2026 | Jill McConnell | Officer | Intent to Sell (Form 144) | -4,892 | $18.19 | – |
| 18 Aug 2026 | Mark Morais | COO & President of Clinical Services | Intent to Sell (Form 144) | -4,892 | $18.19 | – |
| 18 Aug 2026 | Mark Morais | COO & President of Clinical Services | Derivative Exercise and Sale | -4,892 | $18.19 | 82,411 |
| 17 Aug 2026 | Mark Morais | COO & President of Clinical Services | Derivative Exercise and Retained | +6,421 | – | 82,411 |
| 6 Aug 2026 | Carrie Russell | VP of Accounting & Chief Accounting Officer | Initial Statement of Beneficial | +0 | – | 15,325 |
| 5 Aug 2026 | Anshul Thakral | Chief Executive Officer | Open Market Disposition | -111,857 | $18.17 | 204,940 |
| 4 Aug 2026 | Anshul Thakral | Chief Executive Officer | Intent to Sell (Form 144) | -99,869 | $19.16 | – |
| 4 Aug 2026 | Anshul Thakral | Chief Executive Officer | Derivative Exercise and Sale | -99,869 | $19.28 | 316,797 |
| 3 Aug 2026 | Anshul Thakral | Chief Executive Officer | Derivative Exercise and Retained | +316,797 | – | 316,797 |
| 2 Aug 2026 | David Smith | Independent Director | Other Derivative Acquisition | +15,840 | – | 28,692 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 8,571,804 | 8.9% | 3.7 |
| 15 Oct 2026 | 7,675,846 | 8.1% | 4.1 |
| 30 Sep 2026 | 12,564,688 | 13.2% | 7.8 |
| 15 Sep 2026 | 12,550,566 | 13.2% | 10.2 |
| 31 Aug 2026 | 11,937,000 | 12.6% | 11.7 |
| 14 Aug 2026 | 11,501,125 | 12.1% | 6.9 |
No comments yet — be the first to weigh in on FTRE.
Sign in to join the discussion.